📰 Epigenetics Program News
Epigenetics Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Epigenetics Program. Real-time updates on events, politics, business and more.
August 7, 2023
The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.
December 4, 2022
The findings of a recent study headed by Weill Cornell Medicine and NewYork-Presbyterian researchers, suggests that changes in a single gene allow dangerous gut bacteria to trigger the inflammation that underlies Crohns disease.
December 3, 2022
According to a recent study headed by Weill Cornell Medicine and NewYork-Presbyterian researchers, changes in a single gene allow dangerous gut bacteria to trigger the inflammation that underlies Crohns disease
December 2, 2022
Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
November 21, 2022
A new artificial intelligence blood testing technology developed and used by researchers of Johns Hopkins Kimmel Cancer Center to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.
November 21, 2022
A novel artificial intelligence blood testing technology has now detected more than 80% of liver cancers in a new study of 724 people. <br /><br />
November 21, 2022
The test, developed by researchers at the Johns Hopkins Kimmel Cancer Center, aids in early detection of liver cancer&#8212;one of the leading causes of cancer deaths
November 20, 2022
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80% of liver cancers in a new study of 724 people.
November 12, 2022
A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.
October 6, 2022
An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.